What is GE HealthCare Technologies Inc. worth?
With the base-case assumptions below, a discounted cash flow model on GE HealthCare Technologies Inc.'s reported free cash flow gives $39.89 per share. The share price was $66.63 on September 25, 2026, 67% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | -1.0% | 10.0% | $18.13 | -73% |
| Base | 4.0% | 9.0% | $39.89 | -40% |
| Bull | 9.0% | 8.0% | $80.53 | +21% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $55.37 | $60.06 | $65.80 | $72.98 | $82.20 |
| 8.0% | $43.84 | $46.89 | $50.49 | $54.81 | $60.08 |
| 9.0% | $35.41 | $37.49 | $39.89 | $42.70 | $46.01 |
| 10.0% | $28.98 | $30.46 | $32.14 | $34.05 | $36.27 |
| 11.0% | $23.91 | $25.00 | $26.21 | $27.58 | $29.12 |
Where the presets come from
Base: years 1 to 5 grow at GE HealthCare Technologies Inc.'s revenue growth rate over the last 4 fiscal years (4.1% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions